2021 High quality Hypodermic Needle Use - Insulin syringe – Sanxin
2021 High quality Hypodermic Needle Use - Insulin syringe – Sanxin Detail:
The insulin syringe is divided into the nominal capacity by the nominal capacity: 0.5mL, 1mL. Injector needles for insulin syringes are available in 30G, 29G.
The insulin syringe is based on the kinetic principle, using the interference fit of the core rod and the outer sleeve (with the piston), by suction and/or pushing force generated by manual action, for clinical aspiration of liquid medicine and / or injection of liquid medicine, mainly For clinical injection (patient subcutaneous, intravenous, intramuscular injection), health and epidemic prevention, vaccination, etc.
The insulin syringe is a sterile product that is intended for single use only and is sterile for five years. The insulin syringe and the patient are invasive contact, and the use time is within 60 minutes, which is temporary contact.
Product detail pictures:
Related Product Guide:
We stay with the basic principle of "quality initially, services first, steady improvement and innovation to fulfill the customers" for your management and "zero defect, zero complaints" as the quality objective. To perfect our company, we give the goods while using the good high-quality at the reasonable selling price for 2021 High quality Hypodermic Needle Use - Insulin syringe – Sanxin , The product will supply to all over the world, such as: Sierra Leone, Georgia, Naples, Our products are mainly exported to Europe, Africa, America, the Middle East and Southeast Asia and other countries and regions. We have enjoyed a great reputation among our customers for quality products and good services.We would make friends with businessmen from at home and abroad, following the purpose of "Quality First, Reputation First, the Best Services."
By Bertha from San Francisco - 2018.04.25 16:46
We feel easy to cooperate with this company, the supplier is very responsible, thanks.There will be more in-depth cooperation.
By Iris from Malta - 2018.02.08 16:45
